1. Home
  2. ANIP vs DMLP Comparison

ANIP vs DMLP Comparison

Compare ANIP & DMLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIP
  • DMLP
  • Stock Information
  • Founded
  • ANIP 2001
  • DMLP 2003
  • Country
  • ANIP United States
  • DMLP United States
  • Employees
  • ANIP N/A
  • DMLP N/A
  • Industry
  • ANIP Biotechnology: Pharmaceutical Preparations
  • DMLP Oil & Gas Production
  • Sector
  • ANIP Health Care
  • DMLP Energy
  • Exchange
  • ANIP Nasdaq
  • DMLP Nasdaq
  • Market Cap
  • ANIP 1.3B
  • DMLP 1.3B
  • IPO Year
  • ANIP N/A
  • DMLP N/A
  • Fundamental
  • Price
  • ANIP $62.96
  • DMLP $28.00
  • Analyst Decision
  • ANIP Strong Buy
  • DMLP
  • Analyst Count
  • ANIP 8
  • DMLP 0
  • Target Price
  • ANIP $80.13
  • DMLP N/A
  • AVG Volume (30 Days)
  • ANIP 292.6K
  • DMLP 127.6K
  • Earning Date
  • ANIP 08-05-2025
  • DMLP 07-31-2025
  • Dividend Yield
  • ANIP N/A
  • DMLP 11.37%
  • EPS Growth
  • ANIP N/A
  • DMLP N/A
  • EPS
  • ANIP N/A
  • DMLP 2.03
  • Revenue
  • ANIP $674,068,000.00
  • DMLP $166,824,000.00
  • Revenue This Year
  • ANIP $30.17
  • DMLP N/A
  • Revenue Next Year
  • ANIP $7.69
  • DMLP N/A
  • P/E Ratio
  • ANIP N/A
  • DMLP $13.65
  • Revenue Growth
  • ANIP 30.27
  • DMLP 12.09
  • 52 Week Low
  • ANIP $52.50
  • DMLP $25.84
  • 52 Week High
  • ANIP $77.00
  • DMLP $34.88
  • Technical
  • Relative Strength Index (RSI)
  • ANIP 51.66
  • DMLP 50.84
  • Support Level
  • ANIP $61.18
  • DMLP $27.28
  • Resistance Level
  • ANIP $65.19
  • DMLP $28.50
  • Average True Range (ATR)
  • ANIP 1.80
  • DMLP 0.55
  • MACD
  • ANIP 0.55
  • DMLP 0.09
  • Stochastic Oscillator
  • ANIP 71.19
  • DMLP 72.38

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

About DMLP Dorchester Minerals L.P. Common Units Representing Limited Partnership Interests

Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonus, and others. It has leasehold interests in approximately 592 counties and parishes in around 28 states.

Share on Social Networks: